AlphaFold predicted structure
AFF4 · Q9UHB7

Mean pLDDT
53.7/ 100
Low
1,163 residues
Confidence breakdown
- Very high(≥ 90)17%
- Confident(70–90)7%
- Low(50–70)7%
- Very low(< 50)68%
AlphaFold (Jumper et al., 2021) · CC BY 4.0
ALF transcription elongation factor 4
Annotations refreshed 10 hours ago.
Diagnostic Grade (Green)
DDG2P
MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknownFetal anomalies
MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknownIntellectual disability
MONOALLELIC, autosomal or pseudoautosomal, NOT imprintedCognitive impairment-coarse facies-heart defects-obesity-pulmonary involvement-short stature-skeletal dysplasia syndrome
3q26 microduplication syndrome
lung carcinoma
skin basal cell carcinoma
esophageal adenocarcinoma
carcinoma of liver and intrahepatic biliary tract
bile duct carcinoma
colorectal adenocarcinoma
ovarian endometrioid adenocarcinoma with squamous differentiation
kidney neoplasm
Score is the Open Targets composite evidence score (0-1). Higher = stronger gene-disease association.
AF4/FMR2 family member 4
Key component of the super elongation complex (SEC), a complex required to increase the catalytic rate of RNA polymerase II transcription by suppressing transient pausing by the polymerase at multiple sites along the DNA. In the SEC complex, AFF4 acts as a central scaffold that recruits other factors through direct interactions with ELL proteins (ELL, ELL2 or ELL3) and the P-TEFb complex. In case of infection by HIV-1 virus, the SEC complex is recruited by the viral Tat protein to stimulate viral gene expression
Curated MONDO disease pages that list AFF4 among their top associated genes.
AFF4 · Q9UHB7

Mean pLDDT
53.7/ 100
Low
1,163 residues
Confidence breakdown
AlphaFold (Jumper et al., 2021) · CC BY 4.0